ginsenoside rh2 has been researched along with tanshinone in 1 studies
| Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (tanshinone) | Trials (tanshinone) | Recent Studies (post-2010) (tanshinone) |
|---|---|---|---|---|---|
| 295 | 1 | 200 | 1,445 | 10 | 1,033 |
| Protein | Taxonomy | ginsenoside rh2 (IC50) | tanshinone (IC50) |
|---|---|---|---|
| Polycomb protein EED | Homo sapiens (human) | 8.9 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 4.75 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.21 | |
| Tyrosine-protein phosphatase non-receptor type 6 | Homo sapiens (human) | 1.97 | |
| Tyrosine-protein phosphatase non-receptor type 11 | Homo sapiens (human) | 2.57 | |
| Polycomb protein SUZ12 | Homo sapiens (human) | 8.9 | |
| Histone-lysine N-methyltransferase EZH2 | Homo sapiens (human) | 8.9 | |
| Hypoxia-inducible factor 1-alpha | Homo sapiens (human) | 8.51 | |
| Endothelial PAS domain-containing protein 1 | Homo sapiens (human) | 8.51 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, X; He, S; Hu, Y; Liu, Q; Wei, Y; Xu, X; Ye, H; Zhao, C; Zhao, J | 1 |
1 other study(ies) available for ginsenoside rh2 and tanshinone
| Article | Year |
|---|---|
Shenhuangdan decoction alleviates sepsis-induced lung injury through inhibition of GSDMD-mediated pyroptosis.
Topics: Animals; Caspase 1; Chromatography, Liquid; Lung Injury; Mice; Molecular Docking Simulation; NLR Family, Pyrin Domain-Containing 3 Protein; Pyroptosis; Reproducibility of Results; Sepsis; Tandem Mass Spectrometry | 2024 |